The appellate court found the FDA unlawfully changed its rules without providing notice or opportunity for public comment on standards for fulfilling the requirements of applications by creating a substantive rule in the guise of an internal memorandum.
4 minute read
3 minute read
4 minute read
By Katie Hall
4 minute read
6 minute read
By ALM Staff
8 minute read
6 minute read
11 minute read
1 minute read
Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.
